China Advanced Therapy Medicinal Products Cdmo Market Size & Outlook
The advanced therapy medicinal products cdmo market in China is expected to reach a projected revenue of US$ 1,788.6 million by 2030. A compound annual growth rate of 23.9% is expected of China advanced therapy medicinal products cdmo market from 2025 to 2030.
- Biotechnology
- Cell Culture & Stem Cell
- Advanced Therapy Medicinal Products CDMO Market Outlook
- Cell Culture & Stem Cell
Revenue, 2024 (US$M)
$496.5
Forecast, 2030 (US$M)
$1,788.6
CAGR, 2025 - 2030
23.9%
Report Coverage
China
Global Market
Related Markets
China advanced therapy medicinal products cdmo market highlights
- The China advanced therapy medicinal products cdmo market generated a revenue of USD 496.5 million in 2024 and is expected to reach USD 1,788.6 million by 2030.
- The China market is expected to grow at a CAGR of 23.9% from 2025 to 2030.
- In terms of segment, gene therapy was the largest revenue generating product in 2024.
- Cell Therapy is the most lucrative product segment registering the fastest growth during the forecast period.
Advanced therapy medicinal products cdmo market data book summary
| Market revenue in 2024 | USD 496.5 million |
| Market revenue in 2030 | USD 1,788.6 million |
| Growth rate | 23.9% (CAGR from 2025 to 2030) |
| Largest segment | Gene therapy |
| Fastest growing segment | Cell Therapy |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Gene Therapy, Cell Therapy, Tissue Engineered, Others (Combined ATMPs, for example biodegradable matric or scaffold) |
| Key market players worldwide | AGC Inc, Catalent Inc, Lonza Group Ltd, Wuxi AppTec Co Ltd, Cencora Inc, Resonac Holdings Corp, Thermo Fisher Scientific Inc, CELONIC, Bio Elpida, CGT Catapult, Rentschler Biopharma SE |
Other key industry trends
- In terms of revenue, China accounted for 7.5% of the global advanced therapy medicinal products cdmo market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China advanced therapy medicinal products cdmo market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,788.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Advanced Therapy Medicinal Products CDMO Market Scope
Advanced Therapy Medicinal Products CDMO Market segmentation & scope
Advanced Therapy Medicinal Products CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Lonza Group Ltd | View profile | 18,000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | www.lonza.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Wuxi AppTec Co Ltd | View profile | 41,116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | www.wuxiapptec.com |
| AGC Inc | View profile | 61,671 | 1-5-1, Marunouchi, Chiyoda-ku, Tokyo, Japan, 100-8405 | www.agc.com |
| Catalent Inc | View profile | 17,219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | www.catalent.com |
| Cencora Inc | View profile | 46,000 | 1 West First Avenue, Conshohocken, PA, United States, 19428-1800 | www.cencora.com |
| Resonac Holdings Corp | View profile | 23,840 | 1-9-1, Higashi-Shimbashi, Tokyo Shiodome Building, Minato-ku, Tokyo, Japan, 105-7325 | www.resonac.com |
| CELONIC | View profile | 251-500 | Basel, Basel-Stadt, Switzerland, Europe | www.celonic.com |
| Bio Elpida | View profile | 11-50 | Lyon, Rhone-Alpes, France, Europe | www.bio-elpida.com |
| CGT Catapult | View profile | 251-500 | London, England, United Kingdom, Europe | ct.catapult.org.uk |
China Advanced Therapy Medicinal Products CDMO Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Advanced Therapy Medicinal Products CDMO Market Outlook will help companies and investors design strategic landscapes.
Gene Therapy was the largest segment with a revenue share of 59.9% in 2024.
Horizon Databook has segmented the China advanced therapy medicinal products cdmo market based on gene therapy, cell therapy, tissue engineered, others (combined atmps, for example biodegradable matric or scaffold) covering the revenue growth of each sub-segment from 2018 to 2030.
- China Advanced Therapy Medicinal Products Cdmo Market Product Outlook (Revenue, USD Million , 2018-2030)
- Gene Therapy
- Cell Therapy
- Tissue Engineered
- Others (Combined ATMPs, for example biodegradable matric or scaffold)
- China Advanced Therapy Medicinal Products Cdmo Market Phase Outlook (Revenue, USD Million , 2018-2030)
- Phase I
- Phase II
- Phase III
- Phase IV
- China Advanced Therapy Medicinal Products Cdmo Market Indication Outlook (Revenue, USD Million , 2018-2030)
- Oncology
- Cardiology
- Central nervous system
- Musculoskeletal
- Infectious disease
- Dermatology
- Endocrine, metabolic, genetic
- Immunology & inflammation
- Opthalmology
- Haematology
- GasteRoNorth Americanterology
- Others
Reasons to subscribe to Advanced Therapy Medicinal Products CDMO Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Advanced Therapy Medicinal Products CDMO Market Outlook databook
- Our clientele includes a mix of Advanced Therapy Medicinal Products CDMO Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China Advanced Therapy Medicinal Products CDMO Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into China Advanced Therapy Medicinal Products CDMO Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
China Advanced Therapy Medicinal Products Cdmo Market, 2018-2030 (US$M)
China advanced therapy medicinal products cdmo market statistics, by product, 2018-2030 (US$M)
